ArticleJournal of asthma and allergy2024

Japanese Patients with Severe Asthma Identified as Responders to Omalizumab Treatment at 2 Years Based on the GETE Score Continued Treatment for an Extended Period.

Ai Goto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.